What Is Mesothelioma? Symptoms, Causes, and Treatment Options Explained

That last part is no longer entirely true. Treatment has moved on. The options available in 2026 are meaningfully different from what existed a decade ago. That does not make it an easy diagnosis. But it does make the picture more complicated than the adverts suggest.

So let’s talk about what mesothelioma actually is, where it comes from, what it feels like, how it is diagnosed, and what treatment looks like. For patients, for family members, or for anyone who has just been told to "look into it" and does not know where to start.

What Is Mesothelioma, Exactly?

The mesothelium is a thin layer of tissue that lines many of the body's internal organs. Think of it as a kind of protective membrane, sitting between the organ and the surrounding structures.

Mesothelioma is a cancer that starts there.

It tends to produce multiple tumours rather than one localised mass. Those tumours can merge and spread across the surface of an organ in a sheet-like pattern. That is part of what makes it difficult to treat surgically. It is not always something you can simply cut out.

It is also not lung cancer. I say that because pleural mesothelioma, the most common type, affects the lining of the lungs, and the two conditions can look similar on an initial scan. They are different diseases, with different biology and different treatment pathways.

Getting that distinction right matters, and it is one of the reasons early review by an oncology specialist, rather than a general physician, tends to produce a more accurate diagnosis and a more appropriate treatment plan from the outset.

The Different Types

Pleural Mesothelioma

This is by far the most common, accounting for roughly 80% of diagnoses. It affects the pleura, the membrane that surrounds the lungs and lines the chest wall.

Because it is in the chest, the symptoms often mimic lung conditions. Persistent cough, breathlessness, chest discomfort. Things that are easy to attribute to something else for quite a long time.

Peritoneal Mesothelioma

The second most common type. This one affects the peritoneum, the lining of the abdominal and pelvic cavities, so the symptoms are abdominal rather than respiratory.

Here is the interesting bit, and it surprises people: peritoneal mesothelioma often has better outcomes than pleural. Partly because of a specific treatment approach involving surgery combined with heated chemotherapy delivered directly into the abdomen. I will come back to that.

Pericardial Mesothelioma

Extremely rare. It affects the sac around the heart. The symptoms overlap significantly with cardiac conditions, which makes diagnosis genuinely difficult.

Paratesticular Mesothelioma

Rarer still. Affects the tissue lining around the testicles. Often found incidentally, sometimes initially mistaken for a hernia or cyst. Tends to behave differently from the other types, and in some cases has a more favourable outlook.

Cell Type Matters Too

Beyond location, mesothelioma is also classified by the shape of the cancer cells:

• Epithelioid. The most common. Generally the most responsive to treatment.
• Sarcomatoid. More aggressive and harder to treat.
• Biphasic. A mix of both. Prognosis sits somewhere in between.

This is not just academic. Cell type directly affects which treatments are likely to work, and it is central to how a specialist will think about your case.

What Causes It?

Asbestos. Almost always asbestos.

Asbestos is a naturally occurring mineral that was used heavily throughout the 20th century in construction, shipbuilding, insulation, and car manufacturing. Its fibres are durable, heat-resistant, and, as it turned out, profoundly harmful when inhaled or swallowed.

When asbestos fibres enter the body, they embed in tissue. The body cannot break them down or remove them. Over years and decades, that persistent irritation can trigger cancerous changes in mesothelial cells.

The key thing that confuses people is the timeline. There can be 20 to 50 years between the original exposure and a mesothelioma diagnosis. That is not a typo. Someone who worked in construction in the 1970s and was never told about the risks may be receiving a diagnosis today, in their 70s or 80s, for something that started decades ago.

That is why most patients are older men. Not because of anything biological, but because of who was doing which jobs in which industries, and when.

Who Was Most Exposed?

Construction workers, shipbuilders, electricians, plumbers, demolition workers, miners, certain military personnel. Often people who had no idea, at the time, that there was a problem.

Secondary exposure happens, too. Family members who washed work clothing could inhale fibres brought home at the end of a shift. Less common, but documented.

Other Risk Factors

A small number of cases do not involve asbestos. Other recognised risk factors include:

• Erionite. A mineral with similar fibres to asbestos, present in some regions.
• Previous radiation to the chest. Whether occupational or from earlier cancer treatment.
• BAP1 gene mutation. An inherited genetic change that increases susceptibility to mesothelioma and some other cancers. Worth knowing about if there is a family history.

Symptoms

This is the difficult part to communicate clearly.

Mesothelioma symptoms are vague. They develop slowly. They overlap with a long list of more common, less serious conditions. A persistent cough could be a hundred things. Breathlessness in someone in their 70s has a hundred possible causes. Fatigue and weight loss are, unfortunately, fairly nonspecific.

The problem is that this vagueness means people wait. And by the time the symptoms are serious enough that something obviously needs investigating, the disease is often already advanced.

General Symptoms (Any Type)

• Persistent fatigue that does not improve with rest
• Unexplained weight loss
• Fever and night sweats, sometimes coming and going

Pleural Mesothelioma

• Shortness of breath that gradually gets worse
• Persistent cough
• Chest pain, often described as a dull ache under the rib cage
• Difficulty swallowing
• Lumps or thickening felt under the skin on the chest

Fluid around the lungs (pleural effusion) is a common complication and can itself cause significant breathlessness. Draining it provides relief, though it tends to come back.

Peritoneal Mesothelioma

• Abdominal swelling or bloating, caused by fluid in the abdominal cavity
• Persistent abdominal pain
• Nausea, loss of appetite, changes in bowel habit

Pericardial and Paratesticular

Pericardial disease can cause an irregular heartbeat, low blood pressure, and chest discomfort. Paratesticular disease typically shows up as a scrotal or groin lump.

When Should You Actually See Someone?

If you have a history of asbestos exposure and develop any of the above, say so. Tell your doctor about the exposure. Do not assume the breathlessness is just age. That assumption is understandable, and it delays diagnosis.

Even without a known exposure history, symptoms that persist and do not have a clear explanation deserve a proper workup.

If the initial investigation raises any suspicion, push for a referral to a consultant oncologist with experience in thoracic or abdominal cancers. Mesothelioma is uncommon enough that it can be missed or mischaracterised at a general level, and early specialist involvement makes a real difference to how quickly the right diagnosis is reached.

How Is It Diagnosed?

There is no single test. It is a process of building up a picture.

History matters more than people realise. If you have been exposed to asbestos, even decades ago, that information can change the entire direction of an investigation. Mention it. Do not assume the doctor already knows.

Imaging comes next. A chest X-ray is usually the starting point, but it is not definitive on its own. A CT scan gives a much clearer picture of where the disease is and how far it may have spread. A PET scan helps assess whether it has reached lymph nodes or other sites.

Fluid analysis can be useful when fluid has accumulated. Draining and examining it sometimes shows cancer cells, though a tissue biopsy is usually still needed for certainty.

Biopsy is the definitive step. A tissue sample confirms the diagnosis, identifies the cell type, and rules out other conditions that can look similar. Depending on location, this might be done via thoracoscopy, laparoscopy, or CT-guided needle biopsy.

No blood test can diagnose mesothelioma. Some biomarkers can support the picture, but they are a supplement to tissue diagnosis, not a replacement.

Staging

Staging applies mainly to pleural mesothelioma, using a Stage I to IV system.

Stage I and II mean the disease is more localised. More surgical options are available, and outcomes are generally better. Stage III and IV mean the disease has spread further, and the treatment focus shifts more towards control and symptom management.

The reality is that most people are diagnosed at Stage III or IV. The symptoms are nonspecific for long enough that the disease usually has time to progress before anyone puts it together. That is not a comfortable thing to say, but it is the reality of this particular cancer, and it is one reason acting early, when exposure history is present, actually matters.

Treatment Options

Let me be direct about something before going through the list.

Mesothelioma is rarely curable. That is the honest position.

But "not curable" and "not treatable" are not the same thing. Not even close. Effective treatment can extend survival, achieve remission in some patients, and significantly improve quality of life. The goal depends on the stage, the cell type, the individual, and, frankly, the expertise of the team involved.

Surgery is an option for selected patients. Generally, those with earlier-stage disease and sufficient fitness for a major procedure are considered. Extrapleural pneumonectomy removes the affected lung along with the surrounding tissue. Pleurectomy with decortication removes the lining and visible tumour while keeping the lung intact, and is often preferred where feasible. In peritoneal disease, cytoreductive surgery aims to remove as much tumour as possible from the abdominal cavity, often combined with HIPEC.

HIPEC (Hyperthermic Intraperitoneal Chemotherapy) is worth understanding. Heated chemotherapy is delivered directly into the abdomen at the time of cytoreductive surgery. The combination has produced better outcomes in selected patients with peritoneal mesothelioma. It is one of the reasons that type can have a more favourable prognosis than pleural, which surprises a lot of people.

Chemotherapy using a platinum-based combination remains a cornerstone of systemic treatment. It can be given intravenously or, in specific situations, directly into a body cavity.

Immunotherapy has changed the picture in mesothelioma. Checkpoint inhibitors are now used in certain settings and can produce meaningful, sometimes lasting responses. Not everyone responds, and the side effects need managing. But it is a genuine addition to the treatment landscape.

Radiation therapy is mainly used after surgery or for symptom management at specific sites. The proximity of the heart and lungs limits what is possible in terms of dose.

Targeted therapy remains more limited here than in some other cancers, but there is active research, particularly in patients with specific genetic features. Worth asking about at a specialist centre.

Palliative care needs a word of defence, because the phrase is widely misunderstood.

It is not giving up. It is not something that only applies at the end. It is skilled, active management of symptoms. Draining fluid that keeps building. Managing pain properly. Addressing breathlessness. Supporting nutrition. Done well, it allows people to live more comfortably while treatment continues. It belongs alongside oncology care, not after it.

Clinical trials deserve more attention than they usually get.

They are not a last resort. For a cancer like mesothelioma, where standard options are relatively limited, trial access can genuinely change what is available. Ask early whether a trial might be relevant. Do not wait until you have exhausted everything else, because by then some pathways may be closed.

What the Prognosis Numbers Mean

The five-year relative survival rate for pleural mesothelioma is roughly 7% to 24%, depending on stage and cell type. Peritoneal mesothelioma, particularly with cytoreductive surgery and HIPEC, tends to do better.

Those numbers need context.

They reflect patients diagnosed in earlier years, under treatment approaches that have since changed. They include a large proportion of patients diagnosed at advanced stages. And they are averages, which means individual cases vary considerably.

Someone with early-stage, epithelioid cell type, good functional status, and access to a specialist multidisciplinary team is in a very different position from the average in those statistics.

Getting the Right Input

Mesothelioma is uncommon. Not every oncologist sees it regularly. Not every centre has the surgical expertise, the trial access, or the volume of cases that build genuine specialist knowledge.

That matters more than people realise. The difference between being managed at a general centre and being reviewed by a team that deals with this regularly can affect surgical options, trial access, and outcome.

If you have a diagnosis and feel the answers are generic, or you have not been given a clear explanation of all your options, asking for a specialist review is not awkward or difficult. It is reasonable. Most clinicians who are confident in what they are doing will not be bothered by it.

What to Take From This

I‘m not going to dress it up. Mesothelioma is serious. You know that.

But it is also a condition that is increasingly treatable, in the right hands, with the right approach. The story has changed, even if the headlines have not caught up.

If you have an asbestos exposure history and symptoms without a clear explanation, push for a proper workup. Mention the exposure. Do not let it be glossed over.

And if you already have a diagnosis, ask about cell type, staging, immunotherapy, and trials. Ask whether a specialist review would add anything. You are entitled to understand your situation fully.

About Dr James Wilson

Dr James Wilson is a consultant oncologist specializing in lung cancer and advanced radiotherapy. Practicing full-time in Central London, he is dedicated to rapid diagnostic assessment, structured treatment planning, and evidence-based clinical guidance in time-sensitive cases.